Persistent Side Effects of 5-alpha-Reductase Inhibitors
Lasting problems after finasteride or another 5ARI? What a small US study found with questionnaires and blood flow scans, and what it suggests.

Still struggling after taking a 5-alpha-reductase inhibitor (5ARI) for hair loss? Researchers at Baylor College of Medicine studied the long-term side effects, known as post-finasteride syndrome (PFS), in young men who used 5ARIs for androgenic alopecia (AGA). They compared 25 men with a history of 5ARI use with 28 controls.
How did the researchers test the men, and what did they find?
Methodology
Participants completed a series of questionnaires assessing sexual, genitourinary, and psychological health. Additionally, Penile Duplex Doppler Ultrasound (PDDU) was used to evaluate penile vascular health, providing objective data on potential physical changes.
Key Findings
The results were alarming. A significant 68% of the men who had used 5ARIs showed penile vascular abnormalities, suggesting that these medications might have lasting effects on penile blood flow. The men in the 5ARI group also reported significantly higher rates of sexual dysfunction, depression, and genitourinary complaints, including pain, numbness, and loss of penile length.
Psychological Impact
The psychological toll was severe, with 72% of 5ARI users reporting genital discomfort, and notably, two participants in this group died by suicide during or after the study. These findings underline the profound impact that 5ARIs can have on mental health, even long after discontinuation.
Conclusion
This study highlights the persistent and potentially devastating effects of 5ARIs, extending beyond sexual dysfunction to include serious psychological and physical health issues. The findings emphasize the need for healthcare providers to offer comprehensive counseling and close monitoring for patients considering or using 5ARIs for hair loss treatment.
640+ people have joined the registry.
Join them, then report your side effects.
Free. Sign up takes 2 minutes.